Svanesund, Sweden

Kenneth Lundstrom

This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Hassle. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth Lundstrom. Retrieved from https://idiyas.com/inventor/kenneth-lundstrom-dgk8f3oy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth Lundstrom: Innovator in Pharmaceutical Composition

Introduction

Kenneth Lundstrom is a notable inventor based in Svanesund, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative compositions that aim to improve therapeutic outcomes.

Latest Patents

Lundstrom holds a patent for a pharmaceutical composition containing 2-(2-benzimidazolyl thiomethyl). This preparation includes an active ingredient that is a compound of a specific formula, which can be utilized in various therapeutic applications. His patent is recognized for its potential in the pharmaceutical industry, showcasing his expertise and innovative approach.

Career Highlights

Throughout his career, Kenneth Lundstrom has demonstrated a commitment to advancing pharmaceutical science. His work has led to the development of effective compositions that address various medical needs. He is associated with Aktiebolaget Hassle, a company known for its contributions to the pharmaceutical sector.

Collaborations

Lundstrom has collaborated with esteemed colleagues, including Enar I Carlsson and Hakan S Larsson. These partnerships have fostered a collaborative environment that enhances innovation and research in pharmaceutical development.

Conclusion

Kenneth Lundstrom's contributions to pharmaceutical compositions highlight his role as an innovator in the field. His patent and collaborations reflect a dedication to improving healthcare through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…